Showing results (1-10 of 122) with videos related to
Sort By:
Pageof 13
Current Opinion in Oncology|January 6, 2016
The potential of liquid biopsiesAnna Buder, Christian Tomuta, Martin FilipitsTargeted Oncology|December 3, 2020
The Allele Frequency of EGFR Mutations Predicts Survival in Advanced EGFR T790M-Positive Non-small Cell Lung Cancer Patients Treated with OsimertinibAnna Buder, Maximilian J Hochmair, Martin FilipitsTranslational Lung Cancer Research|May 19, 2020
<i>EGFR</i> mutation tracking predicts survival in advanced <i>EGFR</i>-mutated non-small cell lung cancer patients treated with osimertinibAnna Buder, Maximilian J Hochmair, Ulrike Setinek, et al.Experimental and Molecular Pathology|September 24, 2021
Validation of a next-generation sequencing assay for the detection of EGFR mutations in cell-free circulating tumor DNARegina Stitz, Anna Buder, Rene Silye, et al.Current Opinion in Oncology|January 21, 2014
New developments in the treatment of squamous cell lung cancerMartin FilipitsClinical Medicine Insights. Oncology|March 1, 2021
Detection of EGFR Activating and Resistance Mutations by Droplet Digital PCR in Sputum of EGFR-Mutated NSCLC PatientsKlaus Hackner, Anna Buder, Maximilian J Hochmair, et al.Targeted Oncology|February 28, 2019
EGFR Mutations in Cell-free Plasma DNA from Patients with Advanced Lung Adenocarcinoma: Improved Detection by Droplet Digital PCRAnna Buder, Ulrike Setinek, Maximilian J Hochmair, et al.Targeted Oncology|December 13, 2018
Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to OsimertinibMaximilian J Hochmair, Anna Buder, Sophia Schwab, et al.Biomolecules|April 30, 2021
Somatic Copy-Number Alterations in Plasma Circulating Tumor DNA from Advanced EGFR-Mutated Lung Adenocarcinoma PatientsAnna Buder, Ellen Heitzer, Julie Waldispühl-Geigl, et al.Clinical Lung Cancer|September 11, 2018
PD-1 and PD-L1 Protein Expression Predict Survival in Completely Resected Lung AdenocarcinomaBojan Zaric, Luka Brcic, Anna Buder, et al.Pageof 13